| Literature DB >> 35345510 |
Vanessa J Starr1, Edward M Dzialowski1.
Abstract
Background: Chronic exposure to hypoxia during vertebrate development can produce abnormal cardiovascular morphology and function. The aim of this study was to examine cardiac mitochondria function in an avian model, the chicken, in response to embryonic development under hypoxic (15% O2), normoxic (21% O2), or hyperoxic (40% O2) incubation conditions.Entities:
Keywords: AA, Antimycin A; ADP, adenosine diphosphate; COX, cytochrome oxidase; Cardiac mitochondria; Chicken; EP, external pipping; GMP, glutamate, malate, and pyruvate; Hyperoxia; Hypoxia; IP, internal pipping; LEAK, mitochondrial leak respiration; OMY, oligomycin; OXPHOS, mitochondrial oxidative phosphorylation; ROS, reactive oxygen species; ROT, rotenone; Reactive oxygen species; S, succinate; TMPD, N,N,N’,N’-tetramethyl-p-phenylenediamine; dph, days post hatching
Year: 2022 PMID: 35345510 PMCID: PMC8956876 DOI: 10.1016/j.crphys.2022.03.001
Source DB: PubMed Journal: Curr Res Physiol ISSN: 2665-9441
Fig. 1Representative traces for substrate inhibitor protocol used to measure (A) mitochondrial respiration oxygen flux and (B) mitochondrial total reactive oxygen species (H2O2) flux in permeabilized cardiac ventricle muscle fibers of externally pipped chicken embryos and day-old chicken hatchlings. The substrate inhibitor titration protocol consisted of the addition of glutamate, malate, and pyruvate (GMP) supporting Complex I flux in the leak state without ADP (LEAKN-CI), followed by addition of succinate (S) for Complexes I and II flux in the leak state without ADP (LEAKN-CI + CII). ADP (D) was added to support oxidative phosphorylation (OXPHOS) through Complexes I and II. Oligomycin (OMY) and rotenone (Rot) were given for leak states through Complexes I and II (LEAKCI + CII) and Complex II (LEAKCII). Antimycin was provided followed by N,N,N,N′-tetramethyl-p-phenyldiamine and ascorbate (TMPD) to determine maximal oxygen flux through cytochrome oxidase (COX). The chamber was reoxygenated at two points during the run to maintain chamber oxygen above 250 nmol ml−1.
Fig. 2Yolk-free body mass, absolute heart mass, and body mass corrected estimated marginal mean heart mass of EP and 1dph hatchlings incubated in hypoxia (15% O2; EP n = 24; 1 dph n = 16), normoxia (21% O2; EP n = 19; 1 dph n = 19), or hyperoxia (40% O2; EP n = 15; 1 dph n = 21). Incubation in hypoxia or hyperoxia had a large effect on (A) body mass, (B) absolute heart mass, and (C) mass corrected heart mass development. Heart masses presented as either (B) absolute or (C) estimated marginal means ± 95% confidence intervals and body mass as absolute means ± 95% confidence intervals. Open symbols indicate a very large effect of hypoxia or hyperoxia compared with the normoxic values determined by Cohen's d.
Fig. 3Mitochondria respiration of permeabilized cardiac ventricle fibers from A) EP and (B) 1 day old chicken hatchlings incubated in 15% O2, 21% O2, or 40% O2. Mitochondrial O2 flux only differed between incubation treatments at cytochrome c oxidase. Sample sizes are EP-hypoxia n = 21; EP-normoxia n = 22; EP-hyperoxia n = 14; 1dph-hypoxia n = 15; 1dph-normoxia n = 19; 1dph-hyperoxia n = 21. Data presented as mean ± 95% confidence intervals. * indicates a very large effect between the two treatments determined by Cohen's d. Refer to Fig. 1 legend for description of the x axis abbreviations.
Fig. 4Mitochondrial reactive oxygen species (ROS) flux in permeabilized cardiac ventricle fibers from A) externally pipped and (B) 1 day old chicken hatchlings incubated in 15% O2, 21% O2, or 40% O2. There was no effect of incubation O2 level on the production of ROS at either age. Production of H2O2 was greatest in the leak states in the presence of a complex II substrate. Refer to Fig. 1 legend for description of the x axis abbreviations and associated substrates and inhibitors. Sample sizes are EP-hypoxia n = 19; EP-normoxia n = 22; EP-hyperoxia n = 14; 1dph-hypoxia n = 17; 1dph-normoxia n = 16; 1dph-hyperoxia n = 16. presented as mean ± 95% confidence intervals.